Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Experience from the Development of HL7 FHIR IG for Gatekeeper Project.
Gazzarata R, Chronaki C, Gallego A, Gaeta E, Fico G, Zampognaro P, Mercalli F, Giuliani F, Allocca C, Cangioli G. Gazzarata R, et al. Among authors: giuliani f. Stud Health Technol Inform. 2023 Jun 29;305:106-109. doi: 10.3233/SHTI230435. Stud Health Technol Inform. 2023. PMID: 37386969
The Role of HL7 FHIR in the European Project GATEKEEPER.
Gazzarata R, Chronaki C, Gallego A, Gaeta E, Fico G, Zampognaro P, Mercalli F, Giuliani F, Allocca C, Cangioli G. Gazzarata R, et al. Among authors: giuliani f. Stud Health Technol Inform. 2024 Jan 25;310:1337-1338. doi: 10.3233/SHTI231183. Stud Health Technol Inform. 2024. PMID: 38270032
Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence.
Cannarozzi AL, Latiano A, Massimino L, Bossa F, Giuliani F, Riva M, Ungaro F, Guerra M, Brina ALD, Biscaglia G, Tavano F, Carparelli S, Fiorino G, Danese S, Perri F, Palmieri O. Cannarozzi AL, et al. Among authors: giuliani f. United European Gastroenterol J. 2024 Dec;12(10):1461-1480. doi: 10.1002/ueg2.12655. Epub 2024 Aug 31. United European Gastroenterol J. 2024. PMID: 39215755 Free PMC article. Review.
Artificial intelligence: A new tool in the pathologist's armamentarium for the diagnosis of IBD.
Cannarozzi AL, Massimino L, Latiano A, Parigi TL, Giuliani F, Bossa F, Di Brina AL, Ungaro F, Biscaglia G, Danese S, Perri F, Palmieri O. Cannarozzi AL, et al. Among authors: giuliani f. Comput Struct Biotechnol J. 2024 Sep 11;23:3407-3417. doi: 10.1016/j.csbj.2024.09.003. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 39345902 Free PMC article. Review.
Standard Versus Reduced CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: An Observational Multicenter Study.
Fedele P, Landriscina M, Moraca L, Gadaleta-Caldarola A, Cusmai A, Giuliani F, Chiuri V, Giotta F, Pinto A, Mirisola V, Gadaleta-Caldarola G. Fedele P, et al. Among authors: giuliani f. J Clin Med. 2024 Dec 6;13(23):7441. doi: 10.3390/jcm13237441. J Clin Med. 2024. PMID: 39685899 Free PMC article.
[The CCM Project "Guidelines for the Social Reporting of Screening Programmes"].
Betti E, Nappo V, Anghinoni E, Ballotari P, Battisti F, Campari C, Caroli S, Codeluppi C, Marri S, Mantellini P; Gruppo di lavoro sul bilancio sociale. Betti E, et al. Epidemiol Prev. 2024 Nov-Dec;48(6):449-455. doi: 10.19191/EP24.6.A774.127. Epidemiol Prev. 2024. PMID: 39679485 Free article. Italian.
Postnatal growth of etiologically characterized preterm newborns according to gestational age at birth.
Roggero P, Ryumina I, Gunier RB, Winsey A, Rauch SA, Zarco IAC, Ariff S, Rego MAS, Conti CS, Ochieng R, Tuzun F, Asibey J, Giuliani F, Renau MI, Shekharappa CB, Lapillonne A, Tavcioska G, Ismail LC, Menis C, Markelova M, Nieto R, Duah JA, Deantoni S, Madrid BF, Mosca F, Eskenazi B, Lambert A, Bhutta Z, Papageorghiou A, Kennedy S, Villar J. Roggero P, et al. Among authors: giuliani f. Pediatr Res. 2024 Nov 28. doi: 10.1038/s41390-024-03735-x. Online ahead of print. Pediatr Res. 2024. PMID: 39609613
Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The IMPROVE Trial.
Avallone A, Giuliani F, De Stefano A, Santabarbara G, Nasti G, Montesarchio V, Rosati G, Cassata A, Leo S, Romano C, Tamburini E, Silvestro L, Lotesoriere C, Nappi A, Santini D, Petrillo A, Colombo A, Febbraro A, Leone A, Mannavola F, Laterza MM, Izzo F, Sobrero A, Delrio P, Giannarelli D, Budillon A. Avallone A, et al. Among authors: giuliani f. J Clin Oncol. 2024 Nov 22:JCO2400979. doi: 10.1200/JCO.24.00979. Online ahead of print. J Clin Oncol. 2024. PMID: 39576946
Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients.
Mao-Draayer Y, Bar-Or A, Balashov K, Foley J, Smoot K, Longbrake EE, Robertson D, Mendoza JP, Lewin JB, Everage N, Božin I, Lyons J, Mokliatchouk O, Bame E, Giuliani F. Mao-Draayer Y, et al. Among authors: giuliani f. Adv Ther. 2024 Nov 21. doi: 10.1007/s12325-024-03047-w. Online ahead of print. Adv Ther. 2024. PMID: 39570545
467 results